trending Market Intelligence /marketintelligence/en/news-insights/trending/goucdepuvklh3nosg8qrpa2 content esgSubNav
In This List

Allergan adds Catalent executive as CFO/executive vice president

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Allergan adds Catalent executive as CFO/executive vice president

Matthew Walsh resigned from Catalent Inc. and was appointed by Allergan plc as executive vice president and CFO.

Walsh, the executive vice president and CFO at New Jersey-based drugmaker Catalent, will join Allergan later in February following a transition period from his current role.